Primäre und sekundäre (renovaskuläre) arterielle Hypertonie

Literatur

• 1 The ACCORD Study Group . Effects of intensive blood-pressure control in type 2 diabetes mellitus.  N Engl J Med. 2010;  362 1575-1585
  Google Scholar
• 2 ADVANCE Collaborative Group . Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.  Lancet. 2007;  370 829-840
  Google Scholar
• 3 The ARB Trialists Collaboration . Effects of telmisartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals.  J Hypertension. 2011;  29 623-635
  Google Scholar
• 4 Appel L J, Wright J T, Greene T. et al . Intensive blood-pressure control in hypertensive chronic kidney disease.  N Engl J Med. 2010;  363 918-929
  Google Scholar
• 5 The Astral Investigators . Revascularization versus medical therapy for renal-artery stenosis.  N Engl J Med. 2009;  361 1953-1962
  Google Scholar
• 6 Bax L, Woittiez A J, Kouwenberg H J. et al . Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.  Ann Intern Med. 2009;  150 840-848
  Google Scholar
• 7 The ESCAPE Trial Group . Strict blood-pressure control and progression of renal failure in children.  N Engl J Med. 2009;  361 1639-1650
  Google Scholar
• 8 Julius S, Kjeldsen S E, Weber M A. et al . Angiotensin-receptor blockade, cancer, and concerns.  Lancet Oncol. 2010;  11 820-821
  Google Scholar
• 9 Krum H, Schlaich M, Whitbourn R. et al . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.  Lancet. 2009;  373 1275-1281
  Google Scholar
• 10 Peterson J C, Adler S, Burkart J M. et al . Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study.  Ann Intern Med. 1995;  123 754-762
  Google Scholar
• 11 Sandset E C, Bath P MW, Boysen G. et al . The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial.  Lancet. 2011;  377 741-750
  Google Scholar
• 12 Sarnak M J, Greene T, Wang X. et al . The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study.  Ann Intern Med. 2005;  142 342-351
  Google Scholar
• 13 Sipahi I, Debanne S M, Rowland D Y. et al . Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials.  Lancet Oncol. 2010;  11 627-636
  Google Scholar
• 14 Symplicity HTN-2 Investigators . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.  Lancet. 2010;  376 1903-1909
  Google Scholar
• 15 Trinquart L, Mounier-Vehier C, Sapoval M. et al . Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis.  Hypertension. 2010;  56 525-532
  Google Scholar

Prof. Dr. Martin Hausberg

Medizinische Klinik I mit Schwerpunkt Allgemeine
Innere Medizin, Nephrologie, Rheumatologie und Pneumologie
Städtisches Klinikum Karlsruhe

76133 Karlsruhe

Email: martin.hausberg@klinikum-karlsruhe.de

Prof. Dr. Bernhard Krämer

V. Medizinische Klinik Universitätsmedizin Mannheim

Theodor-Kutzer-Ufer 1–3

68167 Mannheim

Email: bernhard.kraemer@umm.de